ALIVUS

Alivus Life Sciences Limited

Pharmaceuticals · ₹14,022 Cr market cap

A specialized pharmaceutical manufacturer focused on developing and producing high-value active pharmaceutical ingredients for chronic disease treatments across multiple therapeutic areas. Operating as a subsidiary of Nirma Limited, a diversified conglomerate, the company serves global specialty pharmaceutical companies through contract development and manufacturing services. Its distinctive strength lies in producing non-commoditized APIs where technical expertise, regulatory compliance, and quality standards are paramount.

3
Tracked investors holding
0
Tracked moves
1,143
Share price

Top investors holding Alivus Life Sciences Limited

Track smart money in Alivus Life Sciences Limited

Get alerted when a top investor buys or sells.

Get started
Alivus Life Sciences Limited — investor holdings & smart-money activity · WhaleWatch